Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics
Clinical trial NCT03535402 · UNKNOWN
Trial details
- NCT number
- NCT03535402
- Sponsor
- Gaylis, Norman B., M.D.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2020-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.